Showing results (91-100 of 117) with videos related to

Sort By:
Pageof 12
Anticancer Research|July 27, 2023
Stent Graft of Pseudoaneurysm Rupture After Subtotal Stomach-preserving PancreaticoduodenectomyKoichi Kimura, Ryosuke Minagawa, Terutoshi Yamaoka, et al.
Asia-Pacific Journal of Clinical Oncology|April 11, 2022
A multi-institutional retrospective study of open versus laparoscopic nephroureterectomy focused on the intravesical recurrenceSoichiro Shimura, Kazumasa Matsumoto, Masaomi Ikeda, et al.
Case Reports in Gastroenterology|November 25, 2010
Carcinosarcoma of the Sigmoid Colon: Report of a CaseYasuharu Mori, Kenji Katsumata, Shouji Suzuki, et al.
Annals of Vascular Surgery|March 4, 2023
Risk Factors for Major Amputation in Chronic Limb-Threatening Ischemia Patients Classified as Wound, Ischemia, and Foot Infection Stage 4 following Infrainguinal RevascularizationKoichi Morisaki, Atsushi Guntani, Daisuke Matsuda, et al.
Bioorganic & Medicinal Chemistry|July 1, 2017
Novel 3H-[1,2,3]triazolo[4,5-c]pyridine derivatives as GPR119 agonists: Synthesis and structure-activity/solubility relationshipsDaisuke Matsuda, Yohei Kobashi, Ayako Mikami, et al.
Journal of Vascular Surgery|April 12, 2025
Influence of heart failure on the clinical outcomes of patients with chronic limb-threatening ischemia after infrainguinal revascularizationKentaro Inoue, Koichi Morisaki, Daisuke Matsuda, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|September 16, 2024
Clinical outcomes of acute limb ischaemia caused by femoropopliteal stent thrombosisSho Nakao, Osamu Iida, Mitsuyoshi Takahara, et al.
Journal of Vascular Surgery|April 19, 2023
Treatment outcomes between bypass surgery and endovascular therapy in patients with chronic limb-threatening ischemia classified as bypass-preferred category based on Global Vascular GuidelinesKoichi Morisaki, Daisuke Matsuda, Atsushi Guntani, et al.
Bioorganic & Medicinal Chemistry Letters|November 8, 2023
Discovery of a novel tetrahydroimidazo[1,2-a]pyridine-5-carboxylic acid derivative as a potent and selective heparanase-1 inhibitor utilizing an improved synthetic approachYudai Imai, Ryo Suzuki, Daisuke Matsuda, et al.
Annals of Vascular Surgery|May 26, 2023
Bypass Surgery Provides Better Outcomes Compared with Endovascular Therapy in Patients with Chronic Limb-Threatening Ischemia Classified as Indeterminate Category According to the Global Vascular GuidelinesShinichiro Yoshino, Koichi Morisaki, Daisuke Matsuda, et al.
Pageof 12